Betagenon AB: First Time In Man-AMPK Activator O304
3/10/2014 10:06:42 AM
STOCKHOLM--(BUSINESS WIRE)--The epidemic increase in obesity has generated a concomitant increase in fatty liver, non-alcoholic steato-hepatitis (NASH) and type 2 diabetes (T2D). Physical inactivity and T2D in elderly are in turn strongly associated with peripheral arterial disease (PAD), caused by reduced blood flow to the legs. Several 100 millions of patients globally live with NASH, T2D or PAD. There are very limited therapeutic options for NASH and PAD, and few new innovative drugs to treat T2D and associated complications. Thus, these diseases represent a serious threat to health care systems globally.
Help employers find you! Check out all the jobs and post your resume.
comments powered by